Show Notes
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, welcome guest Jacqueline Theis, OD, FAAO, who shares her pearls for treating patients with dry eye and a neurologic condition or injury. She explains how to determine whether a patient’s dry eye symptoms are simply dry eye alone, or if they may be related to neurologic problem, and what to do if they are.
More from To the Point
Several investigational therapies are underway—tune in here!
Co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, sit down with Damon Dierker, OD, FAAO, on To the Point to talk about his approach to conjunctivochalasis. Dr. Dierker notes that he prefers to start the dry eye management process by addressing more common patient symptoms, such as inflammation. If symptoms persist, it’s time to introduce conjunctivochalasis as a diagnosis into the conversation. Dr. Dierker covers what to look for and different treatment options, including a more significant intervention that he has found success with: plasma-based conjunctivoplasty. Drs. Garlich and Quint then pick Dr. Dierker’s brain on hyaluronic acid, how he’s integrated it into his clinic, and patient candidacy.
Co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, invite Mila Ioussifova, OD, CNS, FAAO, FOWNS, back on the To the Point podcast to talk about in-office allergy testing. Dr. Ioussifova has built her dry eye and ocular allergy treatment armamentarium over the course of 13 years in practice. She notes that combined, dry eye and ocular allergy can be part of a vicious cycle if the underlying dysregulated immune system isn’t addressed—this is where immunotherapy comes in. Dr. Ioussifova covers her in-office pretesting protocol and the billing and reimbursement behind it.
Kicking off the first episode of the To the Point podcast in 2026, co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, continue the dry eye conversation with DED pearls to implement in clinic. They cover everything from patient signs, symptoms, and side effects to in-office tools, treatments, and therapeutics and OTC options.
In the final 2025 episode of the To the Point podcast, co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, take a moment to look back on the innovations, learnings, and FDA approvals in ocular surface disease over the past year. They also share their vision for dry eye management in 2026, including advances they’re looking forward to and goals they plan to implement in their practices.